ORUDIS Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Orudis, and what generic alternatives are available?
Orudis is a drug marketed by Wyeth Ayerst and Wyeth Cons and is included in two NDAs.
The generic ingredient in ORUDIS is ketoprofen. There are twenty-seven drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the ketoprofen profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Orudis
A generic version of ORUDIS was approved as ketoprofen by TEVA on December 22nd, 1992.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ORUDIS?
- What are the global sales for ORUDIS?
- What is Average Wholesale Price for ORUDIS?
Summary for ORUDIS
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 164 |
| Clinical Trials: | 2 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | ORUDIS at DailyMed |
Recent Clinical Trials for ORUDIS
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Mae Stone Goode Foundation | Phase 2/Phase 3 |
| University of Rochester | Phase 2/Phase 3 |
| Sanford Research | Early Phase 1 |
US Patents and Regulatory Information for ORUDIS
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Wyeth Ayerst | ORUDIS | ketoprofen | CAPSULE;ORAL | 018754-001 | Jul 31, 1987 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Wyeth Cons | ORUDIS KT | ketoprofen | TABLET;ORAL | 020429-001 | Oct 6, 1995 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Wyeth Ayerst | ORUDIS | ketoprofen | CAPSULE;ORAL | 018754-002 | Jan 9, 1986 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Wyeth Ayerst | ORUDIS | ketoprofen | CAPSULE;ORAL | 018754-003 | Jan 9, 1986 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for ORUDIS
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Wyeth Ayerst | ORUDIS | ketoprofen | CAPSULE;ORAL | 018754-001 | Jul 31, 1987 | ⤷ Sign Up | ⤷ Sign Up |
| Wyeth Ayerst | ORUDIS | ketoprofen | CAPSULE;ORAL | 018754-003 | Jan 9, 1986 | ⤷ Sign Up | ⤷ Sign Up |
| Wyeth Ayerst | ORUDIS | ketoprofen | CAPSULE;ORAL | 018754-002 | Jan 9, 1986 | ⤷ Sign Up | ⤷ Sign Up |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for ORUDIS
See the table below for patents covering ORUDIS around the world.
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
